Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M R Veldwijk

Showing results (1-10 of 13) with videos related to

Pageof 2
Sort By:
Expert Opinion on Biological Therapy|December 4, 2003
Prospects and RISC score of viral gene therapy for sarcomaS Fruehauf, M R Veldwijk, W J Zeller, et al.
Stem Cells (Dayton, Ohio)|August 26, 1998
Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cells from steady-state bone marrow and peripheral blood mobilized following G-CSF-supported chemotherapyS Fruehauf, M R Veldwijk, A Krämer, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Superior gene transfer into solid tumour cells than into human mobilised peripheral blood progenitor cells using helpervirus-free adeno-associated viral vector stocksM R Veldwijk, B Schiedlmeier, J A Kleinschmidt, et al.
Cancer Gene Therapy|May 16, 2000
Differential expression of a recombinant adeno-associated virus 2 vector in human CD34+ cells and breast cancer cellsM R Veldwijk, S Fruehauf, B Schiedlmeier, et al.
Human Gene Therapy|July 8, 1999
Soluble bone marrow stroma factors improve the efficiency of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cellsB Schiedlmeier, E C Buss, M R Veldwijk, et al.
Gene Therapy|October 30, 2009
Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O(6)-methylguanine-DNA methyltransferase(P140K)P Maier, I Spier, S Laufs, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 26, 1997
Protection of hematopoietic stem cells from chemotherapy-induced toxicity by multidrug-resistance 1 gene transferS Fruehauf, K Wermann, E C Buss, et al.
British Journal of Haematology|June 3, 1999
Peripheral blood progenitor cell (PBPC) counts during steady-state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony-stimulating factor supported cytotoxic chemotherapy: an update on 100 patientsS Fruehauf, K Schmitt, M R Veldwijk, et al.
Leukemia|May 20, 2005
Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL--Inhibition of P-glycoprotein function by 17-AAGA Radujkovic, M Schad, J Topaly, et al.
Bone Marrow Transplantation|April 24, 2007
Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myelomaS Fruehauf, J Klaus, J Huesing, et al.
Pageof 2

Showing results (1-10 of 13) with videos related to

Sort By:
Pageof 2
Expert Opinion on Biological Therapy|December 4, 2003
Prospects and RISC score of viral gene therapy for sarcomaS Fruehauf, M R Veldwijk, W J Zeller, et al.
Stem Cells (Dayton, Ohio)|August 26, 1998
Delineation of cell cycle state and correlation to adhesion molecule expression of human CD34+ cells from steady-state bone marrow and peripheral blood mobilized following G-CSF-supported chemotherapyS Fruehauf, M R Veldwijk, A Krämer, et al.
European Journal of Cancer (Oxford, England : 1990)|October 26, 1999
Superior gene transfer into solid tumour cells than into human mobilised peripheral blood progenitor cells using helpervirus-free adeno-associated viral vector stocksM R Veldwijk, B Schiedlmeier, J A Kleinschmidt, et al.
Cancer Gene Therapy|May 16, 2000
Differential expression of a recombinant adeno-associated virus 2 vector in human CD34+ cells and breast cancer cellsM R Veldwijk, S Fruehauf, B Schiedlmeier, et al.
Human Gene Therapy|July 8, 1999
Soluble bone marrow stroma factors improve the efficiency of retroviral transfer of the human multidrug resistance 1 gene to human mobilized peripheral blood progenitor cellsB Schiedlmeier, E C Buss, M R Veldwijk, et al.
Gene Therapy|October 30, 2009
Chemoprotection of human hematopoietic stem cells by simultaneous lentiviral overexpression of multidrug resistance 1 and O(6)-methylguanine-DNA methyltransferase(P140K)P Maier, I Spier, S Laufs, et al.
Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|September 26, 1997
Protection of hematopoietic stem cells from chemotherapy-induced toxicity by multidrug-resistance 1 gene transferS Fruehauf, K Wermann, E C Buss, et al.
British Journal of Haematology|June 3, 1999
Peripheral blood progenitor cell (PBPC) counts during steady-state haemopoiesis enable the estimation of the yield of mobilized PBPC after granulocyte colony-stimulating factor supported cytotoxic chemotherapy: an update on 100 patientsS Fruehauf, K Schmitt, M R Veldwijk, et al.
Leukemia|May 20, 2005
Synergistic activity of imatinib and 17-AAG in imatinib-resistant CML cells overexpressing BCR-ABL--Inhibition of P-glycoprotein function by 17-AAGA Radujkovic, M Schad, J Topaly, et al.
Bone Marrow Transplantation|April 24, 2007
Efficient mobilization of peripheral blood stem cells following CAD chemotherapy and a single dose of pegylated G-CSF in patients with multiple myelomaS Fruehauf, J Klaus, J Huesing, et al.
Pageof 2